Early combination therapy with immunoglobulin and steroids is associated with shorter <scp>ICU</scp> length of stay in Multisystem Inflammatory Syndrome in Children ( <scp>MIS‐C</scp> ) associated with <scp>COVID‐19</scp> : A retrospective cohort analysis from 28 U.S. Hospitals-Reference-Cited by-同舟云学术

Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children ( MIS‐C ) associated with COVID‐19 : A retrospective cohort analysis from 28 U.S. Hospitals

Published:2022-06-27 Issue:7 Volume:42 Page:529-539
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Harthan Aaron A.¹^ORCID,Nadiger Meghana²,McGarvey Jeremy S.³,Hanson Keith²^ORCID,Gharpure Varsha P.⁴^ORCID,Bjornstad Erica C.⁵,Chiotos Kathleen⁶,Miller Aaron S.⁷,Reikoff Ronald A.⁸,Gajic Ognjen⁹,Kumar Vishakha¹⁰,Walkey Allan J.¹¹,Kashyap Rahul⁹,Tripathi Sandeep²,

Affiliation:

1. Department of Clinical Pharmacy OSF Healthcare Children's Hospital of Illinois Peoria Illinois USA

2. Department of Pediatrics University of Illinois College of Medicine Peoria Peoria Illinois USA

3. Healthcare Analytics OSF Healthcare Peoria Illinois USA

4. Advocate Children's Hospital Park Ridge Illinois USA

5. University of Alabama at Birmingham Birmingham Alabama USA

6. Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

7. Cardinal Glennon Children's Hospital St Louis Missouri USA

8. M Health‐Fairview University of Minnesota Minneapolis Minnesota USA

9. Mayo Clinic Rochester Minnesota USA

10. Society of Critical Care Medicine Chicago IL USA

11. The Pulmonary Center Department of Medicine Boston University School of Medicine Boston Massachusetts USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2709

Reference36 articles.

1. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment

2. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

3. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves

4. Kawasaki Disease: The Role of Immune Complexes Revisited

5. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Children with SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated with Corticosteroids: A Systematic Review and Meta-Analysis;2024

2. Other Immunomodulatory Treatment for Cytokine Storm Syndromes;Advances in Experimental Medicine and Biology;2024

3. Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study;Pediatric Rheumatology;2023-11-23

4. Cardiovascular effects of COVID-19 in children;Annals of the Academy of Medicine, Singapore;2023-10-30

5. Cardiovascular effects of COVID-19 in children;Annals of the Academy of Medicine, Singapore;2023-10-30